FDA Outsourcing Facility Fee Rate: Fiscal Year 2017

August 5, 2016

According to section 503B(d)(4) of the Federal Food, Drug, and Cosmetic (FD&C) an outsourcing facility is “a facility at one geographic location or address that is engaged in the compounding of sterile drugs; has elected to register as an outsourcing facility; and complies with all of the requirements of section 503B.”  The FD&C Act authorizes the FDA to assess and collect an annual establishment fee from outsourcing facilities, as well as a re-inspection fee for each re-inspection of an outsourcing facility.  These rates are adjusted on an annual basis and are effective from October 1st to September 30th each year.  In addition, the Agency offers a significant discount for qualified small businesses.

Earlier this week, FDA announced its fiscal year 2017 rates, which are as follows:

Qualified Small Business Establishment Fee $5,279
Non-Small Business Establishment Fee $16,852
Re-Inspection Fee $15,837

 

We are extremely qualified and have helped many facilities with the FDA registration process in the past.  To learn more about how we can help your facility register and reduce the total cost to do so, contact us today.

TAGS:

August 13, 2018

FDA Outsourcing Facility User Fee Rates: Fiscal Year 2019

According to a recently released notice from the FDA, “the FD&C Act authorizes FDA to assess and collect an annual establishment fee from outsourcing facilities, as well as a re-inspection fee for...

August 7, 2015

FDA Outsourcing Facility Fee Rates: Fiscal Year 2016

Under the FD&C Act, FDA is authorized to collect annual establishment and reinspection fees from human drug compounding outsourcing facilities. These fees are collected on an annual basis, and...

August 2, 2016

FDA Prescription Drug User Fee Rates: Fiscal Year 2017

The Prescription Drug User Fee Amendments of 2012 (PDUFA V) allows FDA to collect user fees for the review of applications concerning human drug and biological products, the establishments where...